The diagnosis of multiple sclerosis and the clinical subtypes

Barrie J Hurwitz, Barrie J Hurwitz

Abstract

The diagnosis of multiple sclerosis (MS) requires objective findings referable to the central nervous system. A wide differential diagnosis often has to be considered. Magnetic resonance imaging and electrophysiologic and cerebrospinal fluid studies can all contribute to an early definitive diagnosis. The McDonald diagnostic criteria for MS (2005) are the currently recognized MS diagnostic criteria. The clinical subtypes of MS and their diagnosis are discussed in this article. Being informed of the diagnosis may be a stressful experience for the patient and this is also dealt with.

Keywords: Clinical subtypes; Multiple Sclerosis; diagnosis; diagnostic criteria.

Conflict of interest statement

Conflict of Interest: Nil

References

    1. Ebers GC, Sadovick AD. Epidemiology. In: Paty DW, Ebers GC, editors. Multiple sclerosis. Philadelphia: Davis FA; 1998. p. 16.
    1. National MS society. Available from: accessed on 19-03-09.
    1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–31.
    1. Birnbaum G. Making the diagnosis of multiple sclerosis. Adv Neurol. 2006;98:111–24.
    1. Ebers GC. Natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;17:16–9. ii.
    1. Schumaker GA, Beebe G, Kilber RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci. 1965;122:552–68.
    1. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol. 1983;13:227–31.
    1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–7.
    1. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ”McDonald Criteria”. Ann Neurol. 2005;58:840–6.
    1. Miller D, Compston A. The differential diagnosis of multiple sclerosis. In: Compston A, Confavreux C, Lassman H, McDonald I, Miller D, Noseworthy J, et al., editors. McAlpine's Multiple Sclerosis. 4th ed. Philadelphia: Churchill Livingstone Elsevier; 2006. pp. 389–437.
    1. Carmosino MJ, Brousseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: Outcomes and role of magnetic resonance imaging in referral. Arch Neurol. 2005;62:585–90.
    1. Brex PA, Cicarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002;346:158–64.
    1. Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Arch Ophthalmol. 2003;121:944–9.
    1. Tintore M, Riviera A, Rio J, Nos C, Grivé E, Téllez N, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology. 2006;67:968–72.
    1. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000;343:898–904.
    1. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernández O, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomized study. Lancet. 2002;359:1221–31.
    1. Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology. 2006;67:1242–9.
    1. Lebrun C, Bensa C, Debouverie M, De Seze J, Wiertlievski S, Brochet B, et al. Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry. 2008;79:195–8.
    1. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology. 2009;72:800–5.
    1. Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: A multicentre retrospective study. Lancet Neurol. 2007;6:677–86.
    1. Swanton JK, Fernando KT, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77:830–3.
    1. Polman CH. Early diagnosis of multiple sclerosis-still a challenge? Multiple Sclerosis. 2008;14:2–3.
    1. Hawkins SA, McDonald GV. Benign multiple sclerosis? Clinical course, long term follow-up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry. 1999;67:148–52.
    1. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of “benign” multiple sclerosis at 20 years. Neurology. 2007;68:496–500.
    1. Nielson JM, Korteweg T, Polman CH. Diagnosing MS: Recent guidelines and future goals focusing on magnetic resonance imaging. Int MSJ. 2007;14:29–34.
    1. Ford HL, Johnson MH. Telling your patient he/she has multiple sclerosis. Postgrad Med J. 1995;71:449–52.
    1. Heesen C, Kolbeck J, Gold SM, Schulz H, Schulz KH. Delivering the diagnosis of MS- results of a survey among patients and neurologists. Acta Neurol Scand. 2003;107:363–8.
    1. Vitali S. Paraclinical support of the person diagnosed with multiple sclerosis. Int MSJ. 2004;11:2–9.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren